|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,870.00 KRW | -0.22% |
|
-4.41% | +34.53% |
| 2024 | Shinpoong Pharmaceutical Co.,Ltd(KOSE:A019170) dropped from KOSPI 200 Index | CI |
| 2024 | Korean Sugar Imports Plunge 14% as Diabetes Cases Surge | MT |
| Capitalization | 741B 533M 460M 429M 397M 732M 45.83B 822M 5.2B 1.96B 21.46B 2B 1.96B 79.12B | P/E ratio 2023 |
-12.6x | P/E ratio 2024 | -35.7x |
|---|---|---|---|---|---|
| Enterprise value | 739B 531M 459M 428M 396M 731M 45.72B 820M 5.18B 1.95B 21.41B 1.99B 1.95B 78.92B | EV / Sales 2023 |
3.46x | EV / Sales 2024 | 2.43x |
| Free-Float |
58.9% | Yield 2023 * |
-
| Yield 2024 | - |
More valuation ratios
* Estimated data
More news
More press releases
| 1 day | -0.22% | ||
| 1 week | -4.41% | ||
| Current month | -9.52% | ||
| 1 month | +8.27% | ||
| 3 months | +83.71% | ||
| 6 months | +27.13% | ||
| Current year | +34.53% |
| 1 week | 13,540 |  | 14,650 |
| 1 month | 12,780 | | 20,500 |
| Current year | 6,400 | | 20,500 |
| 1 year | 6,400 | | 20,500 |
| 3 years | 6,400 | | 37,500 |
| 5 years | 6,400 | | 214,000 |
| 10 years | 3,750 | | 214,000 |
| Manager | Title | Age | Since |
|---|---|---|---|
Je-Man Yoo
CEO | Chief Executive Officer | 68 | 20/03/2014 |
Jin-Gyu Park
DFI | Director of Finance/CFO | 60 | - |
Chung Joo
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Hyun-Jae Cho
BRD | Director/Board Member | 54 | 28/03/2013 |
Je-Man Yoo
BRD | Director/Board Member | 68 | 20/03/2014 |
Seung-Chul Han
BRD | Director/Board Member | 62 | 29/03/2018 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0% | 89 M€ | +0.42% | - | |
| 0% | 9 M€ | +14.69% | - | |
| 0% | 33,076 M€ | +12.28% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.22% | -4.41% | +15.78% | -49.19% | 533M | ||
| -0.58% | +1.29% | +6.23% | +91.84% | 47.5B | ||
| +1.22% | +1.70% | +31.95% | - | 24.05B | ||
| -1.20% | -1.63% | -10.16% | +35.33% | 23.68B | ||
| -0.01% | -0.18% | -1.62% | +53.23% | 13.92B | ||
| -0.79% | -0.47% | -17.77% | +172.14% | 11.49B | ||
| +10.00% | +17.48% | +87.94% | +111.75% | 8.25B | ||
| -0.05% | +2.04% | +57.46% | +483.43% | 7.3B | ||
| 0.00% | +1.53% | +33.56% | +100.60% | 7.05B | ||
| -.--% | +0.14% | - | - | 6.79B | ||
| Average | +0.84% | +3.62% | +22.60% | +124.89% | 15.06B | |
| Weighted average by Cap. | +0.30% | +2.91% | +13.82% | +109.03% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 200B 144M 124M 116M 107M 198M 12.38B 222M 1.4B 529M 5.8B 540M 529M 21.37B | 221B 159M 137M 128M 118M 218M 13.67B 245M 1.55B 584M 6.4B 596M 584M 23.6B |
| Net income | -57.33B -41.21M -35.56M -33.16M -30.72M -56.65M -3.55B -63.56M -402M -151M -1.66B -155M -151M -6.12B | -15.39B -11.06M -9.54M -8.9M -8.25M -15.21M -952M -17.06M -108M -40.62M -446M -41.49M -40.63M -1.64B |
| Net Debt | -14.43B -10.37M -8.95M -8.35M -7.73M -14.26M -892M -16M -101M -38.09M -418M -38.91M -38.1M -1.54B | -1.86B -1.34M -1.16M -1.08M -999K -1.84M -115M -2.07M -13.07M -4.92M -53.97M -5.03M -4.92M -199M |
More financial data
* Estimated data
Employees
819
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/25 | 13,870.00 ₩ | -0.22% | 319,454 |
| 16/07/25 | 13,900.00 ₩ | -1.35% | 123,683 |
| 15/07/25 | 14,090.00 ₩ | +0.28% | 164,044 |
| 14/07/25 | 14,050.00 ₩ | -3.17% | 223,905 |
| 11/07/25 | 14,510.00 ₩ | 0.00% | 225,387 |
End-of-day quote Korea S.E., July 16, 2025
More quotes
- Stock Market
- Equities
- A019170 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition